Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Last updated: March 26, 2025
Sponsor: Tempus AI
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colorectal Cancer

Colon Cancer; Rectal Cancer

Colon Cancer

Treatment

Observation

Clinical Study ID

NCT05234177
TP-CA-004
  • Ages > 18
  • All Genders

Study Summary

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Known or suspected colorectal adenocarcinoma (Stage I to IVA disease)

  • Planning to undergo or has undergone a surgical resection for suspectedadenocarcinoma of the colon or rectum with curative intent.

  • 18 years old or older

  • Willing and able to provide informed consent

  • Willing to have additional blood samples collected during routine surveillancevisits

Exclusion

Exclusion Criteria:

  • Not willing to have additional blood samples collected

  • Pathology that is not consistent with colorectal adenocarcinoma

Study Design

Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Observation
Phase:
Study Start date:
June 21, 2022
Estimated Completion Date:
February 28, 2029

Connect with a study center

  • Mercy Clinic Oncology - Fort Smith

    Fort Smith, Arkansas 72903
    United States

    Active - Recruiting

  • MemorialCare

    Fountain Valley, California 92708
    United States

    Active - Recruiting

  • The Center for Cancer and Blood Disorders

    Bethesda, Maryland 20817
    United States

    Active - Recruiting

  • Mercy Clinic Oncology and Hematology - Joplin

    Joplin, Missouri 64804
    United States

    Active - Recruiting

  • Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center

    Saint Louis, Missouri 63141
    United States

    Active - Recruiting

  • Mercy Clinic Oncology and Hematology - Sindelar Cancer Center

    Saint Louis, Missouri 63128
    United States

    Active - Recruiting

  • Washington University School of Medicine

    Saint Louis, Missouri 63110
    United States

    Active - Recruiting

  • Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center

    Springfield, Missouri 65804
    United States

    Active - Recruiting

  • Nebraska Cancer Specialists

    Omaha, Nebraska 68130
    United States

    Active - Recruiting

  • Southeastern Medical Oncology Center

    Goldsboro, North Carolina 27543
    United States

    Active - Recruiting

  • Aultman Hospital

    Canton, Ohio 44710
    United States

    Active - Recruiting

  • TriHealth Cancer Institute

    Cincinnati, Ohio 45220
    United States

    Active - Recruiting

  • Ohio State University

    Columbus, Ohio 43210
    United States

    Active - Recruiting

  • OhioHealth Research Institute

    Columbus, Ohio 43214
    United States

    Active - Recruiting

  • Toledo Clinic Cancer Center

    Toledo, Ohio 43623
    United States

    Active - Recruiting

  • Mercy Clinic Oncology and Hematology - Coletta

    Oklahoma City, Oklahoma 73120
    United States

    Active - Recruiting

  • Cancer Care Associates of York

    York, Pennsylvania 17403
    United States

    Active - Recruiting

  • Utah Cancer Specialists

    Salt Lake City, Utah 84124
    United States

    Active - Recruiting

  • University of Washington / Fred Hutchinson Cancer Center

    Seattle, Washington 98109
    United States

    Active - Recruiting

  • ThedaCare Regional Cancer Center

    Appleton, Wisconsin 54911
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.